Chih-Ting Shih Selected Research

protein phosphatase 5

1/2018	Corrigendum to "Inhibition of protein phosphatase 5 suppresses non-small cell lung cancer through AMP-activated kinase activation" [Lung Cancer 112, (October) (2017) 81-89].
1/2018	Corrigendum to "Inhibition of protein phosphatase 5 suppresses non-small cell lung cancer through AMP-activated kinase activation" [Lung Cancer 112 (October) (2017) 81-89].
10/2017	Inhibition of protein phosphatase 5 suppresses non-small cell lung cancer through AMP-activated kinase activation.
1/2017	Protein phosphatase 5 promotes hepatocarcinogenesis through interaction with AMP-activated protein kinase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chih-Ting Shih Research Topics

Disease

4	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 01/2016
4	Neoplasms (Cancer) 10/2017 - 01/2016
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 10/2017
3	Lung Neoplasms (Lung Cancer) 01/2018 - 10/2017
1	Breast Neoplasms (Breast Cancer) 01/2017

Drug/Important Bio-Agent (IBA)

4	protein phosphatase 5IBA 01/2018 - 01/2017
3	AMP-Activated Protein KinasesIBA 01/2018 - 10/2017
3	tissue-factor-pathway inhibitor 2 (PP5)IBA 10/2017 - 01/2017
1	CanagliflozinIBA 01/2019
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2019
1	CateninsIBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	Small Interfering RNA (siRNA)IBA 01/2017
1	Cantharidin (Cantharides)IBA 01/2017
1	Hormones (Hormone)IBA 01/2017
1	palbociclibIBA 01/2017
1	norcantharidinIBA 01/2017
1	4- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA 01/2016

Therapy/Procedure

1	Therapeutics 01/2016